Groh C
Wien Klin Wochenschr Suppl. 1975;40:1-23.
Permanent freedom from fits can be achieved in a large proportion of children with a history of epilepsy through precise individual adjustment and careful maintenance of the therapeutic regimen. A review of the cases treated at the Pediatric Clinic, out-Patient-Department for Epileptics, University of Vienna, reveals that at present about 70% of the patients have a good prognosis (the figures vary from 50 to 85%, depending on the seizure type). An important question which has received only scant attention in the literature arises in the case of patients who have remained free from epileptic fits over a period of many years, namely whether longterm antiepileptic therapy can be terminated and, if so, then when and how. Only very few studies deal specifically with this problem and even these do not provide entirely satisfactory answers to all the posed questions, not only with regard to the optimum time and mode of drug reduction, but also with regard to the principles underlying the choice of apparently suitable candidates for attempted termination of therapy. An attempt is made in this retrospective study comprising 375 patients who have been followed up over a period of at least 5 years, to throw some light on these problems. Indeed, results of statistical significance were obtained by the use of a new mathematical technique, which enables the formulation of new guiding principles in the resolution of all three above-mentioned questions. In consequence, it now appears within the power of the pediatrician to markedly reduce the risk of relapse, which in the case of childhood epilepsies, is about 20%, at present. In general, several basic principles must be adhered to. Total freedom from convulsions over an uninterrupted period of at least 3 years' duration is an absolute prerequisite for consideration of cessation of therapy. Reduction in antiepileptic drug dosage should be carried out as a stepwise procedure over a period of about 2 years. Regular clinical and EEG follow-up examinations should be performed over this period of drug reduction and for 5 years subsequently, in order to recognise and counteract promptly any early signs of possible relapse. The prerequisite convulsionfree period is raised to 4 to 5 years or even longer and the time over which therapy is tailed off increased accordingly in the presence of any of the following criteria: 1. "Endogenous" tendency to relapse, 2. persistence of paroxysmal EEG abnormalities or deterioration of the EEG during the attempt to reduce the dosage of antiepileptic drugs, 3. inveterate epilepsy. The cessation of fits and the termination of medication do not yet signify that all the after-effects of epilepsy are overcome. Social integration must also be achieved before this goal is reached. The psychopathological symptomatology of the patient plays an important role in determining the outcome, whereby the level of intelligence of the patient is the decisive factor...
通过精确的个体化调整和精心维持治疗方案,很大一部分有癫痫病史的儿童能够实现永久性无发作。对维也纳大学癫痫门诊儿科诊所治疗的病例进行回顾发现,目前约70%的患者预后良好(根据发作类型不同,这一数字在50%至85%之间)。对于多年无癫痫发作的患者,一个在文献中很少受到关注的重要问题出现了,即长期抗癫痫治疗是否可以终止,如果可以,那么何时以及如何终止。只有极少数研究专门探讨这个问题,而且即使是这些研究也没有对所有提出的问题给出完全令人满意的答案,不仅在药物减量的最佳时间和方式方面,而且在选择明显适合尝试终止治疗的患者的基本原则方面。在这项对375名患者进行了至少5年随访的回顾性研究中,试图阐明这些问题。事实上,通过使用一种新的数学技术获得了具有统计学意义的结果,这使得能够制定解决上述所有三个问题的新指导原则。因此,现在儿科医生似乎有能力显著降低复发风险,目前儿童癫痫的复发风险约为20%。一般来说,必须坚持几个基本原则。至少连续3年无惊厥发作是考虑停止治疗的绝对前提。抗癫痫药物剂量应在大约2年的时间内逐步减少。在药物减量期间及随后5年内,应定期进行临床和脑电图随访检查,以便及时识别和应对任何可能复发的早期迹象。如果存在以下任何标准,则无惊厥发作的前提时间应延长至4至5年甚至更长,并且相应增加逐渐减少治疗的时间:1. “内源性”复发倾向;2. 在尝试减少抗癫痫药物剂量期间阵发性脑电图异常持续存在或脑电图恶化;3. 顽固性癫痫。惊厥发作停止和药物治疗终止并不意味着癫痫的所有后遗症都已克服。在实现这个目标之前,还必须实现社会融合。患者的精神病理症状在决定结果方面起着重要作用,其中患者的智力水平是决定性因素……